In recent years targeting EGFR has shown some promise; indeed, EGFR is implicated in a variety of cancers including non-small cell lung cancer, colorectal cancer, pancreatic cancer, and head and neck squamous cell carcinoma (HNSCC) (77–81). This evidence concerns the gene EGFR and non-small cell lung carcinoma.